List
Iowa State researchers, left to right, Michael Wannemuehler, Saji Uthaman, Rizia Bardhan and Gregory Phillips in a lab in the Advanced Teaching and Research Building.

Iowa State researchers, left to right, Michael Wannemuehler, Saji Uthaman, Rizia Bardhan and Gregory Phillips are designing and testing nanoparticles to treat inflammatory bowel diseases. Larger photo. Photo by Christopher Gannon/Iowa State University.

AMES, Iowa – Drug-delivering nanoparticles could improve treatments for inflammatory bowel diseases that affect the quality of life of more than 3 million Americans, Iowa State University researchers say.

While there are treatments today, they tend to be short-term, with patients developing resistance to drugs and relapsing into inflammation and symptoms of diarrhea, severe stomach aches, bloody stools and extreme fatigue.

What could help?

Enter the tiny, spherical micelle.

Micelles are self-assembling wonders just 250 billionths of a meter in diameter. The spheres are created when chains of lipid molecules are exposed to water, causing the hydrophilic, water-loving heads of the molecules to form an exterior shell and the water-hating, hydrophobic tails to turn to the inside of the shell.

Rizia Bardhan, an associate professor of chemical and biological engineering at Iowa State University, and other Iowa State researchers say the smart design of micelles could be just the treatment for bowel conditions such as Chron’s disease and ulcerative colitis.

The U.S. Department of Defense’s Congressionally Directed Medical Research Programs are supporting the researchers’ micelle work with a two-year, $306,000 grant.

Bardhan, who has expertise in using nanoparticles for medical applications, is leading the project. Additional team members include:

  • Michael Wannemuehler, with expertise in inflammatory bowel diseases, a professor of veterinary microbiology and preventive medicine
  • Gregory Phillips, with expertise in gut microbiomes, also a professor of veterinary microbiology and preventive medicine
  • And Saji Uthaman, with expertise in the synthesis of micelles, a research scientist in chemical and biological engineering
  • All are affiliated with the Nanovaccine Institute based at Iowa State.

 

Hitting the target, enabling gut health

Bardhan said the researchers will be using hyaluronic acid, a natural biopolymer already used in human medicine, to make therapeutic micelles that can be loaded with a drug that inhibits an immune protein known as STING. Recent studies indicate that activation of the protein can worsen the symptoms of inflammatory bowel diseases.

The U.S. Food and Drug Administration has not approved any drugs that inhibit the STING protein. The researchers say this is, in part, because inhibiting drugs have been tested, but they’re quickly cleared from the body and are difficult to target, so they often fail to reach the inflammation.

“It’s important to target the drug to the inflamed colon,” Bardhan said. “We don’t want it to nonspecifically accumulate in other organs.”

The researchers’ micelles, however, can be loaded with the inhibitor, keeping it in the body for hours. The hyaluronic acid also naturally targets cell receptors expressed in the inflamed colon, bringing the micelles to the inflammation site. Once there, a trigger releases the drug payload.

“The near-term impact of our project will allow a safe micellar formulation of a potent drug for immediate reduction in (inflammatory bowel disease) symptoms with low doses and minimal side effects, and enable a healthy gut environment,” according to Bardhan and Wannemuehler.

Over the long term, the researchers say their STING-inhibiting micelles could impact the design of drug delivery for other conditions linked to STING increases, such as Parkinson’s disease. They said the micelles could also be turned into pills for easy and convenient use.

“The biggest challenge with these inflammatory bowel diseases is there’s no cure,” Bardhan said. “Many patients acquire resistance to existing treatments and those treatments don’t work anymore.”

These new, smartly designed and purpose-built nanoparticles, the researchers said, could be the transformative agents doctors and patients are looking for.

 

  Posts

1 2 3 5
September 17th, 2024

Nigel Reuel receives American Chemical Society BIOT Young Investigator Award

Iowa State University associate professor of chemical and biological engineering Nigel Reuel has received the 2024 American Chemical Society BIOT […]

September 9th, 2024

Black and Veatch Faculty Fellowship for Chowdhury’s AI-based protein design research

Ratul Chowdhury, an assistant professor in the Department of Chemical and Biological Engineering (CBE), was recently named a Black and […]

June 25th, 2024

Reuel receives prestigious American Chemical Society BIOT Young Investigator Award

American Chemical Society graphic announcing Reuel’s award Department of Chemical and Biological Engineering faculty member Nigel Reuel has received the […]

June 11th, 2024

Sullivan Flynn: The right people in his corner 

Sophomore Sullivan Flynn came to Iowa State excited to experience something bigger than himself while also having a group of […]

June 11th, 2024

Mary Thatcher: Prepared for what’s next 

For many students, it can be challenging to determine what path to take. Iowa State’s Chemical and Biological Systems Engineering […]

May 31st, 2024

“No other course is like this:” New class allows chemical engineering students to explore product development

One of the student teams in the initial semester of CH E 4290 poses with the portable oven they developed […]

May 1st, 2024

Victoria Kyveryga: Outstanding senior in chemical engineering

Hometown Ames, Iowa Clubs and activities Ukrainian Club, Engineering Student Council, the Undergraduate Research Ambassadors group, and Central Iowa Symphony.  […]

March 11th, 2024

Wenzhen Li, Jean-Philippe Tessonnier become Royal Society of Chemistry Fellows

Wenzhen Li (left) and Jean-Philippe Tessonnier have become part of an elite group of scientific advocates in the Royal Society […]

March 1st, 2024

“Spirit of innovation” helps lift Jean-Philippe Tessonnier to National Academy of Inventors

Jean-Philippe Tessonnier, Richard C. Seagrave Professor in Chemical and Biological Engineering, has been named a Senior Member of the National […]

February 26th, 2024

Could the future of powering Iowa homes and farms be microbes?

Cyclone Engineer Ratul Chowdhury is advancing biobatteries that use microbes to turn trees and plants into electricity. Chowdhury, an assistant […]